AMIX - AMIX

에 대한 최신 뉴스 Autonomix Medical (NASDAQ:AMIX) 주식

Autonomix Medical

Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Autonomix Medical Inc

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is on the verge of reaching a new all-time high, according to a prominent crypto analyst. The analyst suggests that Bitcoin must break through a significant resistance level to achieve this milestone.
What Happened: Bitcoin could reach a new peak if it surpasses the $64,000 resistance level.
Inmortal, a well-known trader, shared with his 216,300 followers on X that Bitcoin&#8217;s recent decline from around $66,000 to $60,000 might be forming a local bottom. He is considering going long on BTC if it demonstrates a swing failure pattern near $60,000 or gains acceptance above $63,000.
"Breakout above $64,000 = New ATH."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Breakout above 64k = New ATH<a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> <a href="https://t.co/mUvDN5sTyi">pic.twitter.com/mUvDN5sTyi</a>
&mdash; Inmortal (@inmortalcrypto) <a href="https://twitter.com/inmortalcrypto/status/1842200703810633835?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, another analyst, Kaleo, predicts a short-term dip to approximately $57,000 or $58,000 before a rebound. He expects Bitcoin to rise gradually over the next month, especially after the presidential election, advising traders to accumulate during this period.
"Bitcoin. Still looking like a quick little chop to $57,000 or $58,000, followed by a grind higher the rest of the month into a full send post election."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> / <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Still looking like a quick little chop to 57 / 58, followed by a grind higher the rest of the month into a full send post election <a href="https://t.co/QX3wGjPNJQ">pic.twitter.com/QX3wGjPNJQ</a>
&mdash; K A L E O (@CryptoKaleo) <a href="https://twitter.com/CryptoKaleo/status/1841839257096208721?ref_src=twsrc%5Etfw">October 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41100361/remember-sbfs-i-didnt-stash-billions-away-the-latest-ftx-repayment-update-may-have-other-i?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Remember SBF&#8217;s &#8216;I Didn&#8217;t Stash Billions Away&#8217;? The Latest FTX Repayment Update May Have Other Ideas</a>
Why It Matters: The potential for Bitcoin to hit new highs comes amid a backdrop of strong market performance. Recently, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41191566/bitcoin-ethereum-dogecoin-end-the-week-with-strong-gains-summer-lull-seasonality-over-q4-b">cryptocurrency markets</a> have been buoyed by positive labor market data, signaling the end of the summer lull and the start of a bullish fourth quarter.
Additionally, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41185013/bitcoin-rebounds-above-61-500-and-80k-is-more-likely-than-40k-says-top-technical-analyst">technical analysts</a> have noted Bitcoin&#8217;s rebound above $61,500, suggesting that $80,000 is more likely than $40,000. This aligns with the current bullish sentiment, despite some bearish low-timeframe actions.
Furthermore, <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41172369/bitcoin-not-a-safe-haven-but-rising-trump-odds-could-fuel-a-rally-standard-chartered">Standard Chartered</a> has highlighted Bitcoin&#8217;s role as a hedge against traditional financial system issues, rather than geopolitical tensions. This perspective reinforces the notion that Bitcoin&#8217;s price movements are more influenced by financial market dynamics than geopolitical events.
Price Action: At the time of writing, Bitcoin is trading at $62,120, showing a 1.5% increase over the past 24 hours, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41166146/would-bitcoin-drop-if-a-war-in-the-middle-east-breaks-out-yes-but-theres-a-catch?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Would Bitcoin Drop If A War In The Middle East Breaks Out? Yes, But There&#8217;s A Catch</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

Bitcoin Could Hit New All-Time High If It Breaks Above This Resistance Level, Says Analyst

Elon Musk, CEO of SpaceX, has stated that the future of human exploration on Mars is contingent on the <a href="https://www.benzinga.com/topic/2024-election">re-election of former President</a> Donald Trump and the reduction of what he calls &#8220;smothering regulations."
What Happened: Musk, who has thrown his weight behind Trump, endorsed him yet again in the backdrop of <a href="https://www.benzinga.com/news/24/09/41018400/spacex-hits-back-at-faa-chief-for-pinning-starship-delays-on-safety-concerns-every-statement-he-made">SpaceX's struggles</a> with the Federal Aviation Administration, or FAA.
&#8220;Unless Trump wins and we get rid of the mountain of smothering regulations (that have nothing to do with safety!), humanity will never reach Mars. This is existential.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Unless Trump wins and we get rid of the mountain of smothering regulations (that have nothing to do with safety!), humanity will never reach Mars. This is existential. <a href="https://t.co/I9zZuzRvHi">https://t.co/I9zZuzRvHi</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842250303762051263?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41157836/teslas-cybercabs-could-be-a-potential-ride-sharing-disruptor-says-analyst-heres-wha?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla&#8217;s &#8216;Cybercabs&#8217; Could Be A Potential Ride-Sharing Disruptor, Says Analyst</a>
This comes amid escalating tensions between SpaceX and FAA, with Musk <a href="https://www.benzinga.com/news/24/09/41041586/spacex-ceo-elon-musk-calls-for-resignation-of-faa-administrator-mike-whitaker">recently calling for the resignation</a> of FAA chief Mike Whitaker.
Musk&#8217;s company has criticized Whitaker for his defense of delays in SpaceX&#8217;s Starship launch vehicle, claiming that &#8220;every statement he made was incorrect.&#8221;
Why It Matters: The relationship between SpaceX and the FAA has been strained, with Musk accusing the FAA of favoritism towards Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) and proposing a <a href="https://www.benzinga.com/markets/equities/24/09/40912464/elon-musk-accuses-faa-of-fining-spacex-over-nonsense-that-doesnt-affect-safety-amazingly-no-star">$633,009 fine on SpaceX</a> for regulatory violations.
Whitaker has defended the FAA&#8217;s actions, citing safety concerns and regulatory compliance as reasons for the delay in SpaceX&#8217;s Starship launch. He also stated that <a href="https://www.benzinga.com/news/24/09/41016988/spacex-in-violation-of-texas-federal-law-on-some-matters-says-faa-agency-hits-back-at-elon-musks-roc">SpaceX did not adhere</a> to permitting and licensing requirements, which Musk criticized as obstructive.
These ongoing disputes have led Musk to argue that the future of space exploration depends on a political climate that favors deregulation. His recent tweet suggests that he sees a Trump victory as a necessary condition for this to happen.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41161763/european-telecom-giants-threaten-legal-action-against-elon-musks-starlink-over-potential-fcc-rule-ch?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">European Telecom Giants Threaten Legal Action Against Elon Musk&#8217;s Starlink Over Potential FCC Rule Change</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

SPACE

Politics

Tech

General

Elon Musk Says 'Humanity Will Never Reach Mars' Unless Trump Wins: 'This Is Existential'

Former Treasury Secretary Larry Summers has expressed disapproval of the Federal Reserve&#8217;s decision to <a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead">cut interest rates last month</a>, terming it a misstep in the face of the latest US job growth data.
What Happened: On Friday, Summers took to X, formerly Twitter, and voiced his disagreement with the Federal Reserve&#8217;s decision to slash interest rates by 50 basis points in September.
He labeled this action as a &#8220;mistake,&#8221; particularly in light of the recent data that shows <a href="https://www.benzinga.com/trading-ideas/previews/24/10/41170128/jobs-report-preview-could-september-labor-data-shift-feds-interest-rate-path">U.S. job growth</a> exceeding all predictions.
&#8220;Today&#8217;s employment report confirms suspicions that we are in a high neutral rate environment where responsible monetary policy requires caution in rate cutting,&#8221; he said.
See Also: <a href="https://www.benzinga.com/news/24/08/40301145/lawrence-summers-calls-for-sec-investigation-into-unprecedented-vix-movement">Lawrence Summers Calls For SEC Investigation Into Unprecedented VIX Movement</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today's employment report confirms suspicions that we are in a high neutral rate environment where responsible monetary policy requires caution in rate cutting. With the benefit of hindsight, the 50 basis point cut in September was a mistake, though not one of great consequence.…
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1842214555562258679?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41184080/us-economy-adds-254-000-new-jobs-in-september-smashes-expectations-unemployment-f">September jobs report</a> exceeded expectations, showing a 254,000 increase in U.S. payrolls and a surprising drop in the unemployment rate to 4.1%.
Wage growth also outpaced predictions, climbing 0.4% from the previous <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41187740/blowout-september-jobs-report-spurs-reactions-6-economists-say-aggressive-fed-rat">month and 4% over the past</a> year.
Joseph Brusuelas, principal and chief economist at RSM US LLP, highlighted the strong wage increases and dismissed recession concerns, pointing instead to a &#8220;mid-cycle economic expansion.&#8221;
Aditya Bhave, U.S. economist at BofA Securities, adjusted his November forecast to smaller rate cuts (25 basis points) due to the robust economic data.
Bhave predicted a terminal rate of 3.0%-3.25%, with the potential for it to rise further, given the unexpectedly strong productivity growth.
Before the September rate cut, Federal Reserve Chairman Jerome Powell had stated that future interest rate cuts would hinge on economic data. His comments at the time added <a href="https://www.benzinga.com/news/24/09/41102248/stocks-slip-as-powell-says-future-interest-rate-cuts-hinge-on-data-economy-is-in-solid-shape-we-inte">uncertainty to the market</a>, causing stocks to slip.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39875424/larry-summers-biden-quitting-shifts-focus-to-trumps-dishonesty-demagoguery-and-dangerousness-warns-e">Larry Summers: Biden Quitting Shifts Focus To Trump&#8217;s &#8216;Dishonesty, Demagoguery, And Dangerousness&#8217; — Warns Ex-President&#8217;s Policies Will &#8216;Undermine Economic Security Of Tens Of Millions&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Economics

Federal Reserve

Former Treasury Secretary Larry Summers Slams Fed's September Rate Cut Saying It Was A Mistake: 'Today's Employment Report Confirms Suspicions That...'

Department of Transportation Secretary Pete Buttigieg took aim at Elon Musk on Friday over allegations that federal authorities hindered flights delivering aid to <a href="https://www.benzinga.com/topic/hurricane-helene">Hurricane Helene</a> victims.
What Happened: Musk posted a screenshot implying that airspace was &#8220;shut down&#8221; and the Federal Aviation Administration (FAA) was &#8220;throttling flights.&#8221;
Musk voiced his frustration, stating, &#8220;The level of belligerent government incompetence is staggering!!&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just received this text 20 mins ago. The level of belligerent government incompetence is staggering!! <a href="https://t.co/wWbBR7FfUo">pic.twitter.com/wWbBR7FfUo</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842252268856324160?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In response, Buttigieg refuted these claims, asserting that the FAA does not obstruct legitimate rescue and recovery flights. He extended an invitation to Musk to discuss any issues directly, saying, &#8220;If you're encountering a problem give me a call.&#8221;
Following their public exchange, Musk expressed gratitude for a private conversation with Buttigieg, indicating a desire to resolve the matter. &#8220;Thanks for the call. Hopefully, we can resolve this soon,&#8221; Musk wrote, though the details of their discussion remain undisclosed.
See Also: <a href="https://www.benzinga.com/news/24/10/41157285/elon-musks-mom-chimes-in-after-son-says-he-cant-handle-4-years-of-seeing-and-hearing-kamala-harris-a?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s Mom Chimes In After Son Says He Can&#8217;t Handle 4 Years Of &#8216;Seeing And Hearing&#8217; Kamala Harris And Tim Walz</a>
Musk also posted a video showing SpaceX engineers trying to deliver Starlink terminals.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">SpaceX engineers are trying to deliver Starlink terminals &amp; supplies to devastated areas in North Carolina right now and <a href="https://twitter.com/fema?ref_src=twsrc%5Etfw">@FEMA</a> is both failing to help AND won't let others help. This is unconscionable!! They just took this video a few hours ago, where you can see the level of… <a href="https://t.co/abpOsfNenF">pic.twitter.com/abpOsfNenF</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1842284913279586447?ref_src=twsrc%5Etfw">October 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The backdrop of this exchange is the ongoing recovery efforts following Hurricane Helene, which has significantly impacted the region.
<a href="https://www.benzinga.com/news/24/10/41138209/elon-musks-spacex-to-give-free-starlink-access-to-hurricane-helene-victims">Musk&#8217;s SpaceX</a> has been proactive in offering free Starlink access to affected areas, aiming to facilitate communication and aid efforts. This move was part of a broader initiative to deploy a software update ensuring Starlink systems operate without payment in hurricane-affected zones.
Furthermore, the hurricane season has been notably active, with <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41145534/hurricane-helene-adds-to-most-active-quarter-for-power-outages-driving-back-up-gene">Hurricane Helene</a> contributing to widespread power outages, affecting millions. This has driven demand for backup generators, as noted by analysts observing increased consumer interest in such products.
Amidst these challenges, the <a href="https://www.benzinga.com/news/24/10/41195085/white-house-counters-gop-accusations-of-fema-funds-misuse-denies-disaster-relief-funding-was-used-fo">White House</a> has been countering accusations from Republicans regarding the misuse of FEMA funds in the aftermath of the hurricane. These claims have been strongly denied, with officials labeling them as falsehoods.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41195023/kamala-harris-meets-arab-american-leaders-angry-at-us-for-supporting-israel-in-ongoing-conflict-in-g">Kamala Harris Meets Arab American Leaders Angry At US For Supporting Israel In Ongoing Conflict In Gaza: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Gage Skidmore via Flickr

Pete Buttigieg And Elon Musk Clash Over Hurricane Aid Flight Claims

The White House has refuted Republican claims of Federal Emergency Management Agency (FEMA) funds mismanagement following Hurricane Helene.
What Happened: On Friday, Andrew Bates, the senior deputy press secretary, issued a memo accusing Republicans of propagating &#8220;bald-faced lies&#8221; about the post-Hurricane Helene cleanup efforts, <a href="https://thehill.com/homenews/administration/4916014-federal-response-criticized/">reported</a> The Hill.
Republicans, including former President Donald Trump, have claimed&nbsp;that disaster relief funding was&nbsp;spent on migrants, criticizing the administration&#8217;s hurricane response.
Bates denied these allegations, saying, &#8220;No disaster relief funding at all was used to support migrants housing and services. None. At. All.&#8221;
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41156066/elon-musk-cant-contain-his-joy-after-california-deepfakes-law-supported-by-gavin-newsom-blocked-by-c?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Can&#8217;t Contain His Joy After California Deepfakes Law Supported By Gavin Newsom Blocked By Court: &#8216;Yay!&#8217;</a>
He stated that Congress appropriates the funding for migrant support to Customs &amp; Border Protection, and FEMA merely administers it.
Bates also noted&nbsp;that FEMA has already provided&nbsp;over&nbsp;$45 million in direct financial&nbsp;assistance to individuals and families&nbsp;affected by the storm. He cautioned against the potential harm of spreading false information, especially&nbsp;when people are in need.
On the same day, FEMA also released a fact-checking page, confirming that &#8220;no money has been diverted&#8221; and that it has sufficient funds&nbsp;for immediate response and recovery&nbsp;needs.
Why It Matters: Hurricane Helene, which hit on Sept. 26, caused significant damage and <a href="https://www.benzinga.com/news/24/10/41126631/hurricane-helene-devastation-the-latest-on-damage-companies-affected">left nearly 800,000 people</a> without power. The storm claimed more than 130 lives and caused widespread power outages, affecting over two million customers of Duke Energy Corp.
As a result of the hurricane, there was a surge in <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41145534/hurricane-helene-adds-to-most-active-quarter-for-power-outages-driving-back-up-gene">demand for backup and portable</a> power generators.
President Joe Biden has urged Congress to reconvene from recess to approve more funding for recovery efforts, though lawmakers aren't scheduled to return until Nov. 12.
His administration has already sent over 4,800 federal personnel to aid in the response, and the president has authorized the deployment of up to 1,000 troops to assist with North Carolina's recovery, the report noted.
Biden visited North Carolina on Wednesday, followed by trips to Florida and Georgia on Thursday to assess the damage and meet with local leaders.
Previously, Republican presidential nominee Trump allegedly took credit for the deployment of Elon Musk-led Starlink satellites to aid communication restoration in areas affected by Hurricane Helene.
However, FEMA contradicted his statement, saying that the decision was already in <a href="https://www.benzinga.com/news/24/10/41110218/trump-says-he-spoke-with-elon-musk-for-starlink-deployment-to-aid-hurricane-helene-affected-areas-bu">place before Trump's alleged</a> involvement.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41136119/vance-vs-walz-flash-poll-picks-this-candidate-as-tuesdays-debate-winner-but-he-falls-short-in-favora?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Vance Vs. Walz: Flash Poll Picks This Candidate As Tuesday&#8217;s Debate Winner, But He Falls Short In Favorability Rating</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Flickr

Media

White House Counters GOP Accusations Of FEMA Funds Misuse, Denies Disaster Relief Funding Was Used For Migrant Housing: 'Bald-Faced Lies'

Chinese electric vehicle startup Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) announced late Friday that it has struck a partnership with one of its strategic investors to foray into the <a href="https://www.benzinga.com/markets/asia/24/06/39213251/asia-mena-gaming-markets-reach-85-5b-in-2023-see-future-projections">Middle East and North Africa</a>.
What Happened: Nio has tied up with Abu Dhabi-based CYVN Holdings to launch the Nio MENA in a bid to launch Nio-branded vehicles and vehicles from its subsidiary in the region, the Shanghai-based company said in a statement. This, according to the company, will expand its footprint and integrate further into the &#8220;global smart EV ecosystem.&#8221;
CYVN Holdings will support Nio with strategic investments for the expansion, which will start with UAE.
The company also plans to establish a state-of-the-art R&amp;D center in Abu Dhabi, the capital city of UAE. This center will focus on &#8220;autonomous driving and artificial intelligence advancements, reinforcing NIO's global R&amp;D capabilities and fostering technological innovation in the MENA region.&#8221;
Nio and CYVN Holdings plan to collaborate on a new EV project that will involve research, manufacturing, and future product launches. The EV startup would also work with its partners in Egypt to expand EV manufacturing in the country.
In <a href="https://www.benzinga.com/markets/asia/23/12/36281426/nio-stock-up-premarket-after-securing-2-2b-strategic-investment" target="_blank" rel="noreferrer noopener">December Nio closed a $2.2 billion equity investment from</a>&nbsp;CYVN Investments RSC Ltd.
 Jassem Mohamed Obaid Bu Ataba Alzaabi, Chairman of CYVN Holdings, said, &#8220;This partnership is a testament to our mutual commitment to fostering the strength of our strategic collaborations and achieving transformative goals in the smart mobility sector.&#8221;
Nio&#8217;s founder, Chairman and CEO William Li said, &#8220;Our collaboration with CYVN Holdings is a cornerstone in our strategy to enhance global accessibility to smart electric vehicles and to push the boundaries of technological innovation.&#8221;
See Also: <a href="https://www.benzinga.com/money/best-electric-vehicle-stocks">Best EV Stocks</a>
Why It&#8217;s Important: Nio is a manufacturer of premium EVs and it has recently entered the low-end of the market with its Onvo brand. Deliveries of the first vehicle launched by the sub-brand, codenamed&nbsp;L60, began in late September, and early uptake has been fairly strong.
This week, Nio reported <a href="https://www.benzinga.com/markets/equities/24/10/41114350/chinese-ev-trio-nio-xpeng-li-auto-surge-higher-in-tuesdays-premarket-whats-going-on">strong September and record third-quarter deliveries</a> despite the tough domestic EV market conditions marked by lackluster demand and cutthroat competition. 
In late-September, the company said a trio of domestic strategic investors agreed to invest an aggregate of 3.3 billion yuan ($470.64 million) in cash in its subsidiary Nio China. Nio on its part said it would invest 10 billion yuan (about $1.43 billion) in cash to subscribe to the newly issued shares of Nio China.&nbsp;The latest investments would infuse the much-needed financing to pursue it expansion both in China and overseas. 
Nio&#8217;s prospects in China also appear bright, given China has decided to copiously stimulate the domestic economy, potentially arming consumers with the much-needed cash to splurge.
The company currently sells EVs in European countries such as Norway, Sweden, Germany, and the Netherlands. The MENA partnership comes as the <a href="https://www.benzinga.com/markets/equities/24/10/41182675/tesla-byd-and-other-ev-stocks-to-watch-as-eu-votes-to-approve-tariffs-on-chinese-ev-imports">European Commission has voted in favor of up to 45% tariffs on imported Chinese EVs.</a>
Price Action: Nio ended Friday&#8217;s session up 1.04% at $6.77, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data.</a>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41182930/china-was-tipping-into-a-japan-style-lost-decade-of-deflation-and-stagnation-before-late-septemb">China Was Tipping Into A Japan-Style &#8216;Lost Decade&#8217; Of Deflation And Stagnation Before Late-September Stimulus Announcements, Says Legal Expert</a></li>
</ul>
Photo courtesy: Nio

Equities

Tesla Rival Nio Accelerates Global Expansion, To Launch EVs in Middle East Amid EU Tariff Concerns

Democratic Presidential nominee Kamala Harris has reportedly engaged with Arab American and Muslim leaders in Flint, Michigan, amid rising tensions over <a href="https://www.benzinga.com/news/24/06/39562547/us-has-sent-thousands-of-hellfire-missiles-and-2-000-pound-bombs-to-israel-amid-ongoing-war-with-ham">U.S. support for Israel&#8217;s conflicts</a> in Gaza and Lebanon.
What Happened: On Friday, Harris met with representatives from Emgage Action,&nbsp;the American Task Force on&nbsp;Lebanon, and long-time associate Hala Hijazi, reported Reuters, citing two sources.
The meeting is part of a broader effort to reconnect&nbsp;with Muslim and Arab voters,&nbsp;who were instrumental in securing a Democrat win in 2020 but may reconsider their support for Harris in the next election.
Harris addressed the upcoming election and the ongoing Middle East conflicts&nbsp;during the meeting.
She expressed&nbsp;concern over the&nbsp;suffering in Gaza, civilian casualties, and displacement in Lebanon,&nbsp;and discussed efforts to end&nbsp;the war and prevent a regional conflict, the report noted.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41135574/elon-musk-comments-on-jd-vance-tim-walz-debate-after-user-favors-them-over-trump-and-harris-they-wer?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk Comments On JD Vance-Tim Walz Debate After User Favors Them Over Trump And Harris: &#8216;They Were Civil&#8217;</a>
Wa&#8217;el Alzayat, CEO of Emgage&nbsp;Action, said they &#8220;asked Vice President Harris to impress upon President Biden the urgency of bringing an immediate end to the violence&#8221; in Gaza and Lebanon.
However, some Arab Americans believe Harris&#8217; reluctance&nbsp;to distance herself from President&nbsp;Biden&#8217;s Middle East policies could cost her in the upcoming election.
A recent poll&nbsp;by the Arab American Institute&nbsp;found Harris and Trump at&nbsp;roughly even levels of support&nbsp;among Arab Americans.
Why It Matters: The meeting comes amidst a backdrop of escalating tensions in the Middle East.
Last month, <a href="https://www.benzinga.com/news/24/09/40920151/china-slams-us-for-shielding-israel-blocking-gaza-ceasefire-efforts-as-war-nears-1-year">China accused the U.S.</a> of shielding Israel and obstructing ceasefire efforts in the Gaza conflict. &#8220;Had the US not shielded one side time and again, multiple resolutions of this council would not have been flagrantly rejected and defied.&#8221;
Later that month,&nbsp;senior U.S. officials <a href="https://www.benzinga.com/news/24/09/40955425/top-us-officials-skeptical-of-israel-hamas-cease-fire-and-hostage-deal-before-bidens-term-ends-repor">expressed skepticism about a ceasefire</a> and hostage-release deal between Israel and Hamas.
Meanwhile, Israel continued its <a href="https://www.benzinga.com/general/politics/24/09/41056542/israel-plans-to-disrupt-arms-delivery-from-iran-to-lebanon-in-motion-as-palestinian-president-cr">military operations in Lebanon and Gaza</a>.
Earlier in the year, Harris had urged Israeli Prime Minister Benjamin Netanyahu to help establish a Gaza ceasefire, a move that was <a href="https://www.benzinga.com/news/24/08/40417063/trump-says-he-encouraged-netanyahu-to-end-gaza-war-while-critizing-kamala-harris-for-demanding-cease">later criticized by</a> Republican presidential candidate Donald Trump.
&#8220;I will give Israel the support that it needs to win but I do want them to win fast,&#8221; Trump reportedly said in August.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/10/41151338/biden-the-master-oil-trader-part-iv-president-loads-up-on-millions-of-barrels-to-refill-emerg?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Biden The Master Oil Trader Part IV? President Loads Up On Millions Of Barrels To Refill Emergency Stash In &#8216;One Of The Best Oil Trades In History&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Kamala Harris Meets Arab American Leaders Angry At US For Supporting Israel In Ongoing Conflict In Gaza: Report

RPHM

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

CFRA analyst Jonathan Sakraida maintains Ingersoll Rand (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IR#NYSE">IR</a>) with a Hold and raises the price target from $85 to $95.

Price Target

Analyst Ratings

CFRA Maintains Hold on Ingersoll Rand, Raises Price Target to $95

Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has outperformed the market over the past 10 years by 19.23% on an annualized basis producing an average annual return of 30.74%. Currently, Tesla has a market capitalization of $798.69 billion. 
Buying $100 In TSLA: If an investor had bought $100 of TSLA stock 10 years ago, it would be worth $1,446.78 today based on a price of $250.01 for TSLA at the time of writing.
<h3>Tesla's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728077784_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

TSLA

Here's How Much You Would Have Made Owning Tesla Stock In The Last 10 Years

The phrase "the one percent" gets tossed around a lot in conversations about wealth and inequality, whether in politics, protests, or everyday chats. But what does it mean to be in the top 1%? Let's break it down by income and net worth to get a clearer picture of <a href="https://www.benzinga.com/personal-finance/24/09/40711869/how-rich-are-you-heres-the-net-worth-that-defines-upper-middle-and-lower-class">who's part of this exclusive group.</a>
Don't Miss:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>
What Income Puts You in the Top 1%?
To be in the <a href="https://www.benzinga.com/personal-finance/24/07/39652328/your-income-might-be-upper-class-and-you-dont-know-it-heres-the-salary-needed-to-reach-elite-sta">top 1% of earners</a> in the U.S., a household must bring in at least $591,550 a year. For a single individual, the cutoff is $407,500. Remember, these numbers are averages and can vary depending on where you live. For example, earning that much in New York City might not stretch as far as it does in other parts of the country.
The Top 1% by Net Worth
When it comes to net worth, the threshold is even higher. To be part of the top 1% in the U.S., a household's net worth needs to be at least $13.6 million. This measure includes everything you own – homes, investments, savings – minus debts.
Wealth tends to be a lot more unevenly distributed than income. Many households have little to no net worth, while the top tier sits on massive wealth. That's why net worth often gives a clearer picture of someone's financial status than income alone.
Trending: Beating the market through ethical real estate investing' — t<a href="https://www.benzinga.com/money/invest-with-roots">his platform aims to give tenants equity in the homes they live in while scoring 17.17% average annual returns for investors – here&#8217;s how to join with just $100</a>
Income vs. Net Worth: Which Tells the Real Story?
So, which is more important, income or net worth? It depends on what you're trying to measure. Income is great for understanding how much someone earns in a year, but net worth is the better gauge for long-term financial stability and overall wealth. Someone with a high income might not have a high net worth if they spend a lot or have significant debt, while someone with a lower income but solid investments could be much wealthier.
How Many People Are in the 1%?
As of the latest numbers, there are around 1.3 million households and about 1.8 million individual workers who fall into the top 1% in the U.S. That's a small slice of the population but represents a significant share of the country's wealth and income.
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
State-by-State Variations
The income required to be in the top 1% varies significantly across states. For example:
<ul>
<li>Connecticut has the highest threshold at $952,902</li>
<li>Massachusetts follows at $903,401</li>
<li>California comes in third at $844,266</li>
<li>On the lower end, Mississippi has a threshold of just $254,362</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/irs-finalizes-10-year-rule-adv">IRS Finalizes 10-Year Rule For Retirement Withdrawals, Making Things &#8216;Even More Insanely Complicated&#8217;</a>
Understanding <a href="https://www.benzinga.com/personal-finance/24/08/40378006/exactly-how-much-money-do-you-need-to-be-rich-heres-a-look-at-the-numbers">who makes up this elite group</a> isn't just about how much you earn right now but also what you've built over time.&nbsp;
Maybe you're not in the top 1%, or maybe you are – everyone's situation is different. Either way, <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">talking with a financial advisor</a> can be really helpful. They can guide you on where you stand and how to make the best decisions for your financial future, whether you're growing your wealth or looking to manage what you've got.
Read Next:
<ul>
<li>Founder of Personal Capital and ex-CEO of PayPal<a href="https://www.benzinga.com/money/evergreen-money"> re-engineers traditional banking with this new high-yield account — start saving better today.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Personal Finance

Are You Rich Enough To Be In The Top 1%? Here's Both The Income And Net Worth You Need to Rank Among The Wealthiest

STOCK RECEIVES 4TH SIGNAL IN LAST 5 TRADING SESSIONS FOR OVER 5% GAIN 
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="776" height="797" src="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM.png" alt="" class="wp-image-1972" style="width:624px" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM.png 776w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM-292x300.png 292w,https://contributor-assets.benzinga.com/wp-content/uploads/2024/10/04200903/Screen-Shot-2024-10-04-at-4.09.32-PM-768x789.png 768w" sizes="(max-width: 776px) 100vw, 776px" /></figure>
Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:37AM on October 4th, a significant trading signal occurred for Meta Platforms Inc. as it demonstrated a Power Inflow at a price of $582.40. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Meta&#8217;s stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Meta&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock&#8217;s overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for Meta, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data are brought to you by Benzinga APIs</a> and include firms, like <a href="https://finitusa.com/en/">Finit USA</a>, responsible for parts of the data within this article. 
&#xA9; 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
After Market Close UPDATE:
The price at the time of the Power Inflow was $582.40. The returns on the High price ($596.52) and Close price ($595.94) after the Power Inflow were respectively 2.4% and 2.3%%. That is why it is important to have a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite. In this case the high of the day and close were very close but that is not always the case
Past Performance is Not Indicative of Future Results

Signals

Tradepulse Power Inflow Alert: Meta Platforms Inc. Receives Signal And Climbs Over 2.4% On The Day

Throughout the last three months, 7 analysts have evaluated Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $59.57, a high estimate of $65.00, and a low estimate of $54.00. Witnessing a positive shift, the current average has risen by 17.56% from the previous average price target of $50.67.
<img src="https://www.benzinga.com/files/images/story/2024/1728075764_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Newmont is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Murphy</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$63.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Daniel Major</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>David Coleman</td>
<td>Argus Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$58.00</td>
<td>-</td>
</tr>
<tr>
<td>Tanya Jakusconek</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$59.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Jackie Przybylowski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$57.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Matthew Murphy</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Anita Soni</td>
<td>CIBC</td>
<td>Raises</td>
<td>Outperformer</td>
<td>$61.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Newmont. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Newmont compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Newmont's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Newmont's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NEM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Newmont analyst ratings.</a>
<h2>About Newmont</h2>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 6.9 million ounces of gold in 2024. However, after buying Newcrest, Newmont is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
<h3>Newmont's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Positive Revenue Trend: Examining Newmont's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 64.07% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Newmont's net margin excels beyond industry benchmarks, reaching 19.38%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.93%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Newmont's ROA stands out, surpassing industry averages. With an impressive ROA of 1.54%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Newmont's debt-to-equity ratio stands notably higher than the industry average, reaching 0.31. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 7 Analyst Ratings Have To Say About Newmont

During the last three months, 12 analysts shared their evaluations of Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $59.83, along with a high estimate of $70.00 and a low estimate of $40.00. Marking an increase of 13.42%, the current average surpasses the previous average price target of $52.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1728075755_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Lumentum Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Simon Leopold</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$50.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>George Notter</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Richard Shannon</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Meta Marshall</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Tom O'Malley</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$40.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Dave Kang</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$69.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Alex Henderson</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Samik Chatterjee</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Lumentum Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Lumentum Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Lumentum Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LITE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Lumentum Holdings analyst ratings.</a>
<h2>All You Need to Know About Lumentum Holdings</h2>
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
<h3>Unraveling the Financial Story of Lumentum Holdings</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Lumentum Holdings faced challenges, resulting in a decline of approximately -16.86% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Lumentum Holdings's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -81.9%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Lumentum Holdings's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -23.66%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Lumentum Holdings's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -6.21%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Lumentum Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 2.67. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>How Are Analyst Ratings Determined?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LITE

Assessing Lumentum Holdings: Insights From 12 Financial Analysts

Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Quanta Services and provided 12-month price targets. The average target is $297.0, accompanied by a high estimate of $348.00 and a low estimate of $256.00. This upward trend is evident, with the current average reflecting a 3.28% increase from the previous average price target of $287.57.
<img src="https://www.benzinga.com/files/images/story/2024/1728075736_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A clear picture of Quanta Services's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$348.00</td>
<td>$302.00</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$256.00</td>
<td>-</td>
</tr>
<tr>
<td>Marc Bianchi</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$280.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$319.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Gus Richard</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$280.00</td>
<td>$264.00</td>
</tr>
<tr>
<td>Alex Rygiel</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$303.00</td>
<td>$286.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$302.00</td>
<td>$299.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$288.00</td>
<td>$287.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Quanta Services. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Quanta Services compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Quanta Services's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Quanta Services's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PWR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Quanta Services analyst ratings.</a>
<h2>Discovering Quanta Services: A Closer Look</h2>
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under three reportable segments: electric power, renewables infrastructure, and underground utility and infrastructure.
<h3>Quanta Services: A Financial Overview</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Quanta Services showcased positive performance, achieving a revenue growth rate of 10.81% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 3.36%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.91%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Quanta Services's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.2%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.58, Quanta Services adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8 Analysts Assess Quanta Services: What You Need To Know

In the preceding three months, 12 analysts have released ratings for American Intl Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>), presenting a wide array of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $85.25, a high estimate of $93.00, and a low estimate of $77.00. Observing a 0.08% increase, the current average has risen from the previous average price target of $85.18. 
<img src="https://www.benzinga.com/files/images/story/2024/1728075681_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of American Intl Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$90.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Jennings</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$80.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$96.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$77.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$86.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$82.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Michael Ward</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$87.00</td>
<td>$89.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$81.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$93.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Michael Phillips</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$80.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$87.00</td>
<td>$87.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Intl Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Intl Gr compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for American Intl Gr's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of American Intl Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AIG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on American Intl Gr analyst ratings.</a>
<h2>Delving into American Intl Gr's Background</h2>
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a majority stake.
<h3>American Intl Gr: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining American Intl Gr's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -11.75% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: American Intl Gr's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -60.38%, the company may face hurdles in effective cost management.
Return on Equity (ROE): American Intl Gr's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -9.06%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.12%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.22, American Intl Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: American Intl Gr In The Eyes Of 12 Experts

The U.S. Department of Justice (DOJ) is holding firm on its stance that medical marijuana users should not allowed to own a gun, citing safety risks.
In a recent filing, federal attorneys argued that the <a href="https://www.benzinga.com/markets/cannabis/24/06/39488414/cannabis-guns-kentucky-2nd-amendment-meet-the-atf-if-you-say-yes-to-medical-marijuana-the-answer">ban on gun ownership</a> for cannabis users is constitutional and should remain in place. 
This aligns with federal regulations barring gun access for individuals considered potentially dangerous, such as those who are mentally ill or under the influence, <a href="https://www.marijuanamoment.net/doj-says-allowing-a-pennsylvania-prosecutor-who-uses-medical-marijuana-to-possess-a-gun-would-be-dangerous/">reported</a> Marijuana Moment.
<h3 class="wp-block-heading">Pennsylvania Prosecutor Challenges Federal Gun Ban</h3>
This filing responds to <a href="https://www.benzinga.com/markets/cannabis/24/01/36750779/guns-and-weed-conflict-heats-up-pennsylvania-da-sues-feds-over-firearms-ban-for-medical-marijuan">a lawsuit</a> by Robert Greene, the District Attorney of Warren County, Pennsylvania, who is a registered medical marijuana patient. Along with the Second Amendment Foundation, Greene filed suit against the DOJ, Attorney General Merrick Garland and other federal agencies, arguing that the ban infringes on his right to bear arms for self-defense.
The DOJ&#8217;s filing, submitted to the U.S. District Court for the Western District of Pennsylvania, seeks to dismiss Greene&#8217;s suit. 
"Marijuana's physical and mental effects impair a person's judgment, including judgment about whether to use firearms," it says.
The next step for Robert Greene's case involves a federal court decision on his request for a preliminary injunction.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/03/37823911/cannabis-and-guns-legal-battle-heats-up-as-feds-block-weapons-sales-over-weed-smell-lawsuits-ens">Cannabis And Guns: Legal Battle Heats Up As Feds Block Weapons Sales Over Weed Smell, Lawsuits Ensue</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can&#8217;t afford to miss out if you're serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Contradictory Ruling In Texas Gun &amp; Cannabis Rights Case</h3>
Greene's case is not the only legal battle on this issue. In a separate case, the 5th U.S. Circuit Court of Appeals ruled that cannabis users cannot be barred from owning firearms.
The ruling arose from <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">the case</a> of Paola Connelly, a Texas resident whose right to bear arms was upheld despite her past marijuana use. "Marijuana user or not, Paola is a member of our political community and thus has a presumptive right to bear arms," U.S. Circuit Judge Kurt Engelhardt ruled.
The decision is significant because it aligns with <a href="https://www.benzinga.com/markets/cannabis/23/08/33719970/federal-court-strikes-down-gun-prohibition-for-cannabis-users-as-unconstitutional">a 2022 Supreme Court</a> decision stating that firearm laws should reflect historical gun ownership traditions.
While the DOJ has not commented on this ruling, it raises questions about how the federal government will address gun ownership rights among the millions of legal cannabis users nationwide.
<ul>
<li>Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/08/40655441/cannabis-users-cannot-be-barred-from-gun-ownership-u-s-appeals-court-rules">Cannabis Users Cannot Be Barred From Gun Ownership, U.S. Appeals Court Rules </a></li>
</ul>
Cover: AI generated image

Cannabis

Government

Regulations

Legal

Justice Department Defends Ban On Gun Ownership For Medical Cannabis Users

Investors with a lot of money to spend have taken a bullish stance on Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SBUX, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 8 options trades for Starbucks.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 12%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $26,650, and 7, calls, for a total amount of $435,875.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $75.0 to $100.0 for Starbucks during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Starbucks's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Starbucks's whale activity within a strike price range from $75.0 to $100.0 in the last 30 days. 
<h3>Starbucks Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728074755_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$7.8</td>
<td>$7.7</td>
<td>$7.75</td>
<td>$100.00</td>
<td>$155.0K</td>
<td>4.2K</td>
<td style="text-align: right;">203</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$8.15</td>
<td>$8.1</td>
<td>$8.15</td>
<td>$95.00</td>
<td>$86.3K</td>
<td>1.3K</td>
<td style="text-align: right;">126</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$2.83</td>
<td>$2.75</td>
<td>$2.75</td>
<td>$100.00</td>
<td>$50.6K</td>
<td>10.5K</td>
<td style="text-align: right;">213</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$17.45</td>
<td>$17.3</td>
<td>$17.38</td>
<td>$80.00</td>
<td>$43.5K</td>
<td>6.6K</td>
<td style="text-align: right;">27</td>
</tr>
<tr>
<td>SBUX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$21.1</td>
<td>$20.45</td>
<td>$21.04</td>
<td>$75.00</td>
<td>$42.0K</td>
<td>174</td>
<td style="text-align: right;">12</td>
</tr>
</tbody>
</table>

<h3>About Starbucks</h3>
Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 38,000 stores across more than 80 countries as of the end of fiscal 2023. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.
In light of the recent options history for Starbucks, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Starbucks Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 5,418,853, with SBUX's price up by 1.13%, positioned at $96.64.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 27 days.</li>
</ul>
<h3>Expert Opinions on Starbucks</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $104.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Bernstein has elevated its stance to Outperform, setting a new price target at $115. 
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Starbucks, maintaining a target price of $105. 
&#x2A; An analyst from BMO Capital persists with their Outperform rating on Starbucks, maintaining a target price of $110. 
&#x2A; An analyst from Jefferies downgraded its action to Underperform with a price target of $76. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Starbucks with a target price of $118. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Starbucks, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

SBUX

Check Out What Whales Are Doing With SBUX

Financial giants have made a conspicuous bearish move on Dollar Tree. Our analysis of options history for Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) revealed 9 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $60,260, and 7 were calls, valued at $925,315.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $100.0 for Dollar Tree over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Dollar Tree stands at 686.0, with a total volume reaching 13,653.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Dollar Tree, situated within the strike price corridor from $55.0 to $100.0, throughout the last 30 days.
<h3>Dollar Tree 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728074750_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.83</td>
<td>$2.65</td>
<td>$2.69</td>
<td>$85.00</td>
<td>$416.9K</td>
<td style="text-align: right;">730</td>
<td>1.5K</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.81</td>
<td>$2.67</td>
<td>$2.69</td>
<td>$85.00</td>
<td>$269.0K</td>
<td style="text-align: right;">730</td>
<td>2.5K</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$9.3</td>
<td>$9.2</td>
<td>$9.25</td>
<td>$75.00</td>
<td>$71.2K</td>
<td style="text-align: right;">240</td>
<td>79</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$2.8</td>
<td>$2.78</td>
<td>$2.77</td>
<td>$85.00</td>
<td>$65.9K</td>
<td style="text-align: right;">730</td>
<td>2.9K</td>
</tr>
<tr>
<td>DLTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$2.81</td>
<td>$2.75</td>
<td>$2.78</td>
<td>$85.00</td>
<td>$45.1K</td>
<td style="text-align: right;">730</td>
<td>2.7K</td>
</tr>
</tbody>
</table>

<h3>About Dollar Tree</h3>
Dollar Tree operates discount stores across the United States and Canada, with over 8,600 shops under its namesake banner and nearly 7,800 under Family Dollar. About 47% of Dollar Tree's sales in fiscal 2023 were composed of consumables (including food, health and beauty, and cleaning products), around 45% from variety items (including toys and homewares), and over 5% from seasonal items. The Dollar Tree banner sells most of its merchandise at the $1.25 price point and positions its stores in well-populated suburban markets. Conversely, Family Dollar primarily sells consumable merchandise (80% of the banner's sales) at prices below $10. About two-thirds of Family Dollar's stores are located in urban and suburban markets, with the remaining one-third located in rural areas.
After a thorough review of the options trading surrounding Dollar Tree, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Dollar Tree's Current Market Status</h3>
<ul>
<li>With a trading volume of 3,407,814, the price of DLTR is up by 2.63%, reaching $70.9.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 54 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Dollar Tree</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $80.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from BMO Capital has revised its rating downward to Market Perform, adjusting the price target to $68. 
&#x2A; An analyst from Melius Research downgraded its action to Hold with a price target of $70. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a In-Line rating on Dollar Tree with a target price of $78. 
&#x2A; An analyst from Loop Capital downgraded its action to Hold with a price target of $65. 
&#x2A; An analyst from Guggenheim persists with their Buy rating on Dollar Tree, maintaining a target price of $120. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Dollar Tree with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

DLTR

This Is What Whales Are Betting On Dollar Tree

Financial giants have made a conspicuous bearish move on Cava Group. Our analysis of options history for Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) revealed 11 unusual trades.
Delving into the details, we found 18% of traders were bullish, while 72% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $84,462, and 9 were calls, valued at $1,730,287.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $140.0 for Cava Group over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Cava Group's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cava Group's whale trades within a strike price range from $60.0 to $140.0 in the last 30 days. 
<h3>Cava Group Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728074744_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$64.9</td>
<td>$64.8</td>
<td>$64.8</td>
<td>$60.00</td>
<td>$1.2M</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">200</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$12.1</td>
<td>$12.0</td>
<td>$12.0</td>
<td>$135.00</td>
<td>$114.0K</td>
<td style="text-align: right;">547</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/11/24</td>
<td>$3.6</td>
<td>$3.3</td>
<td>$3.57</td>
<td>$126.00</td>
<td>$71.9K</td>
<td style="text-align: right;">237</td>
<td style="text-align: right;">234</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$14.9</td>
<td>$14.2</td>
<td>$14.1</td>
<td>$125.00</td>
<td>$70.5K</td>
<td style="text-align: right;">909</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/11/24</td>
<td>$2.95</td>
<td>$2.65</td>
<td>$2.65</td>
<td>$128.00</td>
<td>$53.0K</td>
<td style="text-align: right;">56</td>
<td style="text-align: right;">241</td>
</tr>
</tbody>
</table>

<h3>About Cava Group</h3>
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.
In light of the recent options history for Cava Group, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Cava Group</h3>
<ul>
<li>Currently trading with a volume of 1,895,183, the CAVA's price is up by 1.38%, now at $126.65. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 32 days.</li>
</ul>
<h3>Professional Analyst Ratings for Cava Group</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $127.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from TD Securities keeps a Buy rating on Cava Group with a target price of $130. 
&#x2A; An analyst from TD Cowen downgraded its action to Buy with a price target of $115. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Cava Group, which currently sits at a price target of $130. 
&#x2A; Maintaining their stance, an analyst from Argus Research continues to hold a Buy rating for Cava Group, targeting a price of $128. 
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Neutral, setting a price target of $135. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cava Group, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

CAVA

Decoding Cava Group's Options Activity: What's the Big Picture?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Medical device firm Autonomix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) popped into traders&rsquo; radar on Monday, peaking at 150% before engaging in choppy trading. An announcement of a licensing agreement with&nbsp;RF Innovations, a privately held medical technology specialist, catapulted sentiment. The news established credibility for AMIX stock as the underlying enterprise moves to develop solutions for disorders related to the peripheral nervous system.



According to the accompanying <a href="https://finance.yahoo.com/news/autonomix-enters-definitive-agreement-license-120000743.html">press release</a>, the agreement centers on the Apex 6 Generator, which is a pain management technology. The deal enables Autonomix a &ldquo;perpetual non-exclusive worldwide and royalty-free license of the Apex 6 Generator intellectual property.&rdquo; On the other end, Autonomix will issue RF 250,000 shares of AMIX stock.



Per the release, Autonomix intends to leverage the technology in its strategic therapeutic units to enhance value for its pipeline. &ldquo;This transaction represents a significant step forward for the development and commercialization of our innovative technology platform and can potentially simplify our regulatory strategy, as the Apex 6 Generator is already FDA-cleared in pain management,&rdquo; stated President and CEO Brad Hauser.



Ultimately, the deal may help illuminate nervous-system-related diseases and improve how such conditions are diagnosed and treated.



<h2>AMIX Stock May Benefit From a Burgeoning Ecosystem</h2>



Another factor to consider regarding AMIX stock is the broader pain management market. In terms of the domestic drugs sector, the ecosystem was <a href="https://finance.yahoo.com/news/pain-management-drugs-market-size-161000945.html">worth $29.99 billion in 2022</a>. Experts at Precedence Research believe that it could expand to $41.72 billion by 2032, implying a compound annual growth rate of 3.4%.



More specifically, Grand View Research notes that the global pain management device market was worth $6.92 billion in 2022. Analysts anticipate that from 2023 to 2030, the segment will expand at a CAGR of 9.5%. At the culmination point, the market <a href="https://www.grandviewresearch.com/industry-analysis/pain-management-devices-market">could be valued at $14.14 billion</a>. With AMIX stock carrying a market capitalization of a little over $28 million, there&rsquo;s theoretically significant room to run.



At the same time, Autonomix is a speculative enterprise. The company made its public market debut in late January of this year. Even with today&rsquo;s dramatic surge, AMIX stock is off the pace by around 70%. It&rsquo;s also worth noting that Autonomix is a pre-revenue entity. Therefore, it&rsquo;s a highly speculative play without analyst coverage.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-up-120-today/">Why Is Autonomix Medical (AMIX) Stock Up 120% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Autonomix Medical (AMIX) Stock Up 120% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!



Moving stocks are new agreements, a patent, a public offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>SILO Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) stock is rocketing more than 69% after <a href="https://www.nasdaq.com/press-release/silo-pharma-secures-exclusive-global-license-alzheimers-therapeutic-2024-07-16">securing a new license</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) shares are soaring over 65% with heavy pre-market trading.</li>



<li>SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) stock is surging more than 39% on a <a href="https://www.nasdaq.com/press-release/scisparc-announces-us-patent-application-treating-metabolic-syndrome-and-weight-loss">new weight loss patent</a>.</li>



<li>Meiwu Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/wnw-stock-quote/">WNW</a>) shares are rising over 30% with strong early morning trading.</li>



<li>Singing Machine (NASDAQ:<a href="https://investorplace.com/stock-quotes/mics-stock-quote/">MICS</a>) stock is increasing more than 25% on a <a href="https://www.nasdaq.com/press-release/singing-machines-subsidiary-semicab-announces-over-9-million-contracted-revenue">$9 million revenue backlog contract</a>.</li>



<li>Passage Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/pasg-stock-quote/">PASG</a>) shares are gaining over 18% on <a href="https://www.nasdaq.com/press-release/passage-bio-announces-positive-feedback-fda-expansion-uplift-d-trial-pbft02-include">clinical trial expansion feedback</a>.</li>



<li>AEON Biopharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/aeon-stock-quote/">AEON</a>) stock is climbing more than 16% with strong pre-market trading.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) shares are getting an over 12% boost after <a href="https://www.stocktitan.net/news/SISI/shineco-announces-closing-of-2-million-underwritten-public-r9iot7ulzqfp.html">closing a public offering</a>.</li>



<li>SMX (Security Matters) (NASDAQ:<a href="https://investorplace.com/stock-quotes/smx-stock-quote/">SMX</a>) stock is jumping more than 11% <a href="https://www.nasdaq.com/press-release/smx-announces-effective-date-reverse-stock-split-2024-07-11">following a reverse stock split</a>.</li>



<li>Biomerica (NASDAQ:<a href="https://investorplace.com/stock-quotes/bmra-stock-quote/">BMRA</a>) shares are up over 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Autonomix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock is diving more than 18% <a href="https://www.nasdaq.com/press-release/autonomix-enters-definitive-agreement-license-intellectual-property-fda-cleared">following a rally yesterday</a>.</li>



<li>Vince (NYSE:<a href="https://investorplace.com/stock-quotes/vnce-stock-quote/">VNCE</a>) shares are tumbling over 17% without any clear news this morning.</li>



<li>TuanChe (NASDAQ:<a href="https://investorplace.com/stock-quotes/tc-stock-quote/">TC</a>) stock is taking a more than 17% beating on Tuesday morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are sliding over 17% after <a href="https://www.nasdaq.com/press-release/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-bank-islam-trust">rising yesterday on a strategic alliance</a>.</li>



<li>Lottery.com (NASDAQ:<a href="https://investorplace.com/stock-quotes/ltry-stock-quote/">LTRY</a>) stock is dropping more than 16% on Tuesday.</li>



<li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) shares are decreasing over 16% this morning.</li>



<li>Tantech (NASDAQ:<a href="https://investorplace.com/stock-quotes/tanh-stock-quote/">TANH</a>) stock is falling more than 15% despite a lack of news this morning.</li>



<li>MF International (NASDAQ:<a href="https://investorplace.com/stock-quotes/mfi-stock-quote/">MFI</a>) shares are slipping over 14% on Tuesday morning.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is dropping close to 14% <a href="https://www.benzinga.com/news/24/07/39781479/cyngn-shares-were-up-by-more-than-50-whats-going-on">after a recent rally</a>.</li>



<li>Lixiang Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/lxeh-stock-quote/">LXEH</a>) shares close out our pre-market stock movers down more than 12% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-16th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Autonomix Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock is taking a beating on Tuesday after the development stage medical device company saw its shares undergo a rally yesterday.



That came as it provided updates on its <a href="https://finance.yahoo.com/news/autonomixs-trial-results-show-meaningful-173000465.html">pancreatic cancer pain management device</a>. This includes positive results from a clinical trial covering its device. This uses radiofrequency (<a href="https://investorplace.com/stock-quotes/rf-stock-quote/">RF</a>) ablation to reduce the pain of patients with pancreatic cancer.



On top of that, Autonomix Medical also <a href="https://www.nasdaq.com/press-release/autonomix-enters-definitive-agreement-license-intellectual-property-fda-cleared">announced a definitive agreement</a> with&nbsp;RF Innovations to license the intellectual property of its Apex 6 Radiofrequency Generator. The deal is set to be completed by the end of the month.



All of this news resulted in shares of AMIX stock rallying 130% during normal trading hours yesterday. That came with heavy trading as some 152 million shares changed hands. For the record, its daily average trading volume is about 3 million shares.



<h2>AMIX Stock Movement on Tuesday</h2>



Considering the massive rally AMIX stock saw yesterday, it makes sense it would give up some of those gains the following day. This has the stock down 16.7% as of Tuesday morning.



Trading activity this morning has more than 1.3 million shares on the move. That&rsquo;s still below the company&rsquo;s daily average trading volume.



Investors will want to stick around for more of the most recent stock market stories on Tuesday!



We have all of the hottest market happenings traders need to know about today! A few examples include what&rsquo;s happening with shares of Conduit Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>), Silo Pharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) and Rumble&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/rum-stock-quote/">RUM</a>) stock today. All of that news is ready at the links below!



<h2>More Tuesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-conduit-pharmaceuticals-cdt-stock-up-73-today/">Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-silo-pharma-silo-stock-up-123-today/">Why Is Silo Pharma (SILO) Stock Up 123% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/trade-of-the-day-buy-rumble-rum-stock-call-options-as-trump-trades-gain/">Trade of the Day: Buy Rumble (RUM) Stock Call Options as Trump Trades Gain</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-down-17-today/">Why Is Autonomix Medical (AMIX) Stock Down 17% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Autonomix Medical (AMIX) Stock Down 17% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Greenpro Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) stock is dropping on Tuesday after the financial consulting and corporate advisory services company&rsquo;s shares underwent a large rally during the prior day of trading.



This saw shares of GRNQ stock close out normal trading hours on Monday up more than 34%. That came with heavy trading as over 10 million units moved yesterday. To put that number in perspective, the daily average trading volume for Greenpro Capital shares is around 183,000.



This rally didn&rsquo;t come without any news. The catalyst behind it was Greenpro Capital announcing a new strategic partnership. This brings together Greenpro Capital, its subsidiary Green-X and Bank Islam Trust Company.



Greenpro Capital CEO Dr. CK Lee <a href="https://www.nasdaq.com/press-release/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-bank-islam-trust">said this about the strategic alliance</a>.




&ldquo;We are extremely excited to have&nbsp;Bank Islam Trust&nbsp;as our strategic partner to penetrate the Muslim and&nbsp;Middle East&nbsp;communities. There is a huge demand for digital asset investments from the&nbsp;Middle East, and we will structure our STO and RWA assets as alternative investment products to cater to their demand.&rdquo;




<h2>GRNQ Stock Movement Today</h2>



Considering the rally yesterday, it makes sense that GRNQ stock would give up some of those gains today. That has the stock falling 19.1% as of Tuesday morning. Traders will note that GRNQ shares were down 5.6% year-to-date when markets closed yesterday.



Today&rsquo;s stock market movement comes with some 230,000 shares of GRNQ on the move. That&rsquo;s already above Greenpro Capital&rsquo;s daily average trading volume.



Investors will want to keep reading for more of the biggest stock market stories on Tuesday!



We have all of the hottest stock market happenings to report on today! That includes the latest news for Autonomix Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock, Conduit Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock and Silo Pharma&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/">SILO</a>) stock this morning. All of this info is ready to go at the links below!



<h2>More Stock Market News for Tuesday</h2>



<ul><li><a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-down-17-today/">Why Is Autonomix Medical (AMIX) Stock Down 17% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-conduit-pharmaceuticals-cdt-stock-up-73-today/">Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-silo-pharma-silo-stock-up-123-today/">Why Is Silo Pharma (SILO) Stock Up 123% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-greenpro-capital-grnq-stock-down-19-today/">Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
SciSparc (NASDAQ:<a href="https://investorplace.com/stock-quotes/sprc-stock-quote/">SPRC</a>) stock is up on Tuesday after the clinical-stage pharmaceutical company <a href="https://finance.yahoo.com/news/scisparc-announces-u-patent-application-100300054.html">announced a new patent</a> application covering its weight loss treatment.



SciSparc notes that this patent covers the company&rsquo;s collaboration with Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>). This is a clinical-stage biotech company focused on psychedelic-derived therapeutics.



This patent covers the novel proprietary composition of Palmitoylethanolamide. This is the active ingredient in SciSparc&rsquo;s proprietary CannAmide. It&rsquo;s used alongside Clearmind Medicine&rsquo;s MEAI compound to treat metabolic syndrome and obesity.



Here&rsquo;s what SpcSparc had to say about the new patent.




&ldquo;Overall, as part of this collaboration, twelve other patent applications have been filed by Clearmind with the USPTO for various compositions, including the proprietary composition of SciSparc&rsquo;s PEA with Clearmind&rsquo;s MEAI compound for the treatments of alcohol use disorder, cocaine addiction and obesity and its related metabolic disorders.&rdquo;




<h2>What This Means for SPRC Stock</h2>



SciSparc could reach a large market with its obesity treatment. The Centers for Disease Control and Prevention (<a href="https://investorplace.com/stock-quotes/cdc-stock-quote/">CDC</a>) estimates that 41.9% of adults over the age of 20 are obese. This saw the market reach $15 billion in 2022.



SPRC stock is up 24.6% as of Tuesday morning. This comes with some 37 million shares traded. That&rsquo;s well above its daily average trading volume of about 138,000 shares.



Investors will want to stick around for more of the most recent stock market stories today!



We have all of the hottest stock market news traders need to know about on Tuesday! Among that is what has shares of Match Group&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mtch-stock-quote/">MTCH</a>), Greenpro Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) and Autonomix Medical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) stock moving today. You can read all about that at the links below!



<h2>More Tuesday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/07/mtch-stock-alert-activist-starboard-value-is-betting-big-on-match-group/">MTCH Stock Alert: Activist Starboard Value Is Betting Big on Match Group</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-greenpro-capital-grnq-stock-down-19-today/">Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?</a></li>



<li><a href="https://investorplace.com/2024/07/why-is-autonomix-medical-amix-stock-down-17-today/">Why Is Autonomix Medical (AMIX) Stock Down 17% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/why-is-scisparc-sprc-stock-up-25-today-july-16th/">Why Is SciSparc (SPRC) Stock Up 25% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is SciSparc (SPRC) Stock Up 25% Today?

IPO Roundup: Pershing Square, Actuate Therapeutics and more

Autonomix Medical, Inc. reports Q1 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Autonomix Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/amix-stock-quote/">AMIX</a>) just reported results for the first quarter of 2025.<ul><li>Autonomix Medical reported earnings per share of -14 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/amix-stock-earnings-autonomix-medical-for-q1-of-2025/">AMIX Stock Earnings: Autonomix Medical Reported Results for Q1 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AMIX Stock Earnings: Autonomix Medical Reported Results for Q1 2025

Autonomix rises after it reports reduction of pain in pancreatic cancer patients

Autonomix rises after it reports reduction of pain in pancreatic cancer treatment

ACTU

AEIBU

AEON

AMIX

ANRO

BMRA

CMND

DTSQU

FBLG

GRNQ

GUTS

LINE

LTRY

LXEH

LZMH

MBAVU

MICS

MTCH

OSTX

PASG

PSHZF

SILO

SISI

SPHAU

SPRC

TANH

TZUP

VNCE

Screenshot 2024-10-02 at 5.21.14 PM

Biotech

This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer

Screenshot 2024-07-11 at 9.17.30 PM

Autonomix&#39;s Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

Screenshot 2024-06-12 at 6.28.14 PM

Movers & Shakers

Discover How This Company&#39;s Breakthrough Technology Might Be The Key To Transforming Pancreatic Cancer Pain Relief

Screenshot 2024-06-05 at 7.12.02 PM

This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management

Screenshot 2024-05-07 at 11.14.55 PM

Health Care

3000x More Sensitive Than What Is On The Market – This Technology Moves The Needle

Screenshot 2024-04-10 at 6.42.30 PM

Autonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat Diseases

The Nervous System Is Central To The Body, Yet Limited CNS Diagnostic Tools Exist – This Company Wants To Change That

Press Releases

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients

Comments

Autonomix Medical

뉴스

에 대한 최신 뉴스 Autonomix Medical (NASDAQ:AMIX) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌